Home

Aarti Drugs Ltd 52 Week Low

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

YEARLOW

₹ 378.9

Last updated on: Feb 12, 2025

Key Highlights

  • The 52 Week Low of Aarti Drugs Ltd is ₹ 378.9 as of 12 Feb 25 .

Company Fundamentals for Aarti Drugs Ltd

Market Price of Aarti Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Feb 2025383.25
12 Feb 2025393.5
11 Feb 2025393.75
10 Feb 2025404.8
07 Feb 2025415.65
06 Feb 2025423.85
05 Feb 2025417.05
04 Feb 2025414.9
03 Feb 2025424.4
01 Feb 2025413.4

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Drugs Ltd

No data available

* All values are in crore

Aarti Drugs Ltd News Hub

Aarti Drugs hit 52-week high as board OKs Rs 60-cr share buyback

The buyback price fixed at Rs 900 per equity share, representing a 59.66% premium to Friday's closin

Read more

26 Aug 24

Aarti Drugs to consider buyback

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 26 August 2024. Powered

Read more

22 Aug 24

Aarti Drugs soars on share buyback proposal

The announcement was made after market hours yesterday. Aarti Drugs forms part of $6 Billion Aarti G

Read more

22 Aug 24

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up to 6,65,00

Read more

26 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Aarti Drugs Ltd

Why is it important to track the 52-week low of Aarti Drugs Ltd stocks?

Investors should monitor the 52-week low of Aarti Drugs Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Aarti Drugs Ltd stocks hitting a 52-week low?

Factors leading to Aarti Drugs Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Aarti Drugs Ltd stocks when they hit a 52-week low?

Buying Aarti Drugs Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Aarti Drugs Ltd stocks?

Investors should monitor the 52-week low of Aarti Drugs Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Aarti Drugs Ltd stock at their 52-week low?

An investor can analyze the reasons for the Aarti Drugs Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Aarti Drugs Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Aarti Drugs Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Aarti Drugs Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions